Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy

Vaccine

Volumn 28, Issue 19, 2010, Pages 3371-3378

  Pluhar, G Elizabeth ^a   Grogan, Patrick T ^a   Seiler, Charlie ^a   Goulart, Michelle ^a   SantaCruz, Karen S ^b   Carlson, Cathy ^a   Chen, Wei ^a   Olin, Mike R ^a   Lowenstein, Pedro R ^c   Castro, Maria G ^c   Haines, Stephen J ^a   Ohlfest, John R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Adenovirus; Canine glioma; CpG ODN; Gemistoctyic astrocytoma; Interferon gamma

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN G; PROTEIN HYDROLYSATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; BLOOD CHEMISTRY; CANCER IMMUNIZATION; CD8+ T LYMPHOCYTE; CELL COUNT; CELL CULTURE; CELL GROWTH; CELL LYSATE; CELL THERAPY; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GLIOMA CELL; HEMIPARESIS; IMMUNIZATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; VACCINATION;

ADENOVIRIDAE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, NEOPLASM; ASTROCYTOMA; CD8-POSITIVE T-LYMPHOCYTES; CELL EXTRACTS; DOG DISEASES; DOGS; GENE THERAPY; GENETIC VECTORS; IMMUNOTHERAPY, ACTIVE; INTERFERON-GAMMA; OLIGODEOXYRIBONUCLEOTIDES;

EID: 77950628522     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.082     Document Type: Article

References (46)

1. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
2. Wen P.Y., and Kesari S. Malignant gliomas in adults. N Engl J Med 359 (2008) 492-507
3. Krouwer H.G., Davis R.L., Silver P., and Prados M. Gemistocytic astrocytomas: a reappraisal. J Neurosurg 74 (1991) 399-406
4. Tihan T., Vohra P., Berger M.S., and Keles G.E. Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective. J Neurooncol 76 (2006) 175-183
5. Kimmelman J., and Nalbantoglu J. Faithful companions: a proposal for neurooncology trials in pet dogs. Cancer Res 67 (2007) 4541-4544
6. Stoica G., Kim H.T., Hall D.G., and Coates J.R. Morphology, immunohistochemistry, and genetic alterations in dog astrocytomas. Vet Pathol 41 (2004) 10-19
7. Candolfi M., Curtin J.F., Nichols W.S., Muhammad A.G., King G.D., Pluhar G.E., et al. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neurooncol 85 (2007) 133-148
8. Lipsitz D., Higgins R.J., Kortz G.D., Dickinson P.J., Bollen A.W., Naydan D.K., et al. Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs. Vet Pathol 40 (2003) 659-669
9. Foster E.S., Carrillo J.M., and Patnaik A.K. Clinical signs of tumors affecting the rostral cerebrum in 43 dogs. J Vet Intern Med 2 (1988) 71-74
10. Heidner G.L., Kornegay J.N., Page R.L., Dodge R.K., and Thrall D.E. Analysis of survival in a retrospective study of 86 dogs with brain tumors. J Vet Intern Med 5 (1991) 219-226
11. LeCouter R.A. Brain tumors of cats and dogs. Vet Med Rep 2 (1990) 332-342
12. Turrel J.M., Fike J.R., LeCouteur R.A., and Higgins R.J. Computed tomographic characteristics of primary brain tumors in 50 dogs. J Am Vet Med Assoc 188 (1986) 851-856
13. LaRue S.M., and Gillette E.L. Small animal clinical oncology (2001), WB Saunders Co Publishing, Philadelphia p. 119-137
14. Wu A., Oh S., Gharagozlou S., Vedi R.N., Ericson K., Low W.C., et al. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma. J Immunother 30 1997 (2007) 789-797
15. Krieg A.M. Development of TLR9 agonists for cancer therapy. J Clin Invest 117 (2007) 1184-1194
16. Ehtesham M., Samoto K., Kabos P., Acosta F.L., Gutierrez M.A., Black K.L., et al. Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer. Cancer Gene Ther 9 (2002) 925-934
17. Wu A., Oh S., Ericson K., Demorest Z.L., Vengco I., Gharagozlou S., et al. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma. Cancer Gene Ther 14 (2007) 550-560
18. Wu A., Wiesner S., Xiao J., Ericson K., Chen W., Hall W.A., et al. Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy. J Neurooncol 83 (2007) 121-131
19. Wakabayashi T., Natsume A., Hashizume Y., Fujii M., Mizuno M., and Yoshida J. A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy. J Gene Med 10 (2008) 329-339
20. Chiocca E.A., Smith K.M., McKinney B., Palmer C.A., Rosenfeld S., Lillehei K., et al. A phase I trial of Ad.hIFN-beta gene therapy for glioma. Mol Ther 16 (2008) 618-626
21. Yu J.S., Liu G., Ying H., Yong W.H., Black K.L., and Wheeler C.J. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64 (2004) 4973-4979
22. Yamanaka R., Abe T., Yajima N., Tsuchiya N., Homma J., Kobayashi T., et al. Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial. Br J Cancer 89 (2003) 1172-1179
23. Selznick L.A., Shamji M.F., Fecci P., Gromeier M., Friedman A.H., and Sampson J. Molecular strategies for the treatment of malignant glioma-genes, viruses, and vaccines. Neurosurg Rev 31 (2008) 141-155 [discussion 155]
24. Saito R., Mizuno M., Nakahara N., Tsuno T., Kumabe T., Yoshimoto T., et al. Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma. Int J Cancer 111 (2004) 777-782
25. Jiang X.B., Lu X.L., Hu P., and Liu R.E. Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma. Vaccine 27 (2009) 6210-6216
26. Suni M.A., Maino V.C., and Maecker H.T. Ex vivo analysis of T-cell function. Curr Opin Immunol 17 (2005) 434-440
27. Rubio V., Stuge T.B., Singh N., Betts M.R., Weber J.S., Roederer M., et al. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 9 (2003) 1377-1382
28. Zaritskaya L., Shafer-Weaver K.A., Gregory M.K., Strobl S.L., Baseler M., and Malyguine A. Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trials. J Immunother 32 (2009) 186-194
29. Biller B.J., Elmslie R.E., Burnett R.C., Avery A.C., and Dow S.W. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet Immunol Immunopathol 116 (2007) 69-78
30. Poduslo J.F., Curran G.L., and Berg C.T. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc Natl Acad Sci USA 91 (1994) 5705-5709
31. Fine R.L., Chen J., Balmaceda C., Bruce J.N., Huang M., Desai M., et al. Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors. Clin Cancer Res 12 (2006) 5770-5776
32. Kuratsu J., Itoyama Y., Uemura S., and Ushio Y. Regrowth patterns of glioma-cases of glioma regrew away from the original tumor. Gan No Rinsho 35 (1989) 1255-1260
33. Silbergeld D.L., and Chicoine M.R. Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 86 (1997) 525-531
34. Daga A., Orengo A.M., Gangemi R.M., Marubbi D., Perera M., Comes A., et al. Glioma immunotherapy by IL-21 gene-modified cells or by recombinant IL-21 involves antibody responses. Int J Cancer 121 (2007) 1756-1763
35. Pallasch C.P., Struss A.K., Munnia A., Konig J., Steudel W.I., Fischer U., et al. Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival. Int J Cancer 117 (2005) 456-459
36. Ghulam Muhammad A.K., Candolfi M., King G.D., Yagiz K., Foulad D., Mineharu Y., et al. Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression. Clin Cancer Res 15 (2009) 6113-6127
37. von Budingen H.C., Gulati M., Kuenzle S., Fischer K., Rupprecht T.A., and Goebels N. Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands". J Neuroimmunol 218 (2010) 134-139
38. Solter P.F., Hoffmann W.E., Chambers M.D., Schaeffer D.J., and Kuhlenschmidt M.S. Hepatic total 3 alpha-hydroxy bile acids concentration and enzyme activities in prednisone-treated dogs. Am J Vet Res 55 (1994) 1086-1092
39. Thawani N., Tam M., Chang K.H., and Stevenson M.M. Interferon-gamma mediates suppression of erythropoiesis but not reduced red cell survival following CpG-ODN administration in vivo. Exp Hematol 34 (2006) 1451-1461
40. Yuan J., Gnjatic S., Li H., Powel S., Gallardo H.F., Ritter E., et al. CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proc Natl Acad Sci USA 105 (2008) 20410-20415
41. Ciuffreda D., Comte D., Cavassini M., Giostra E., Buhler L., Perruchoud M., et al. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 38 (2008) 2665-2677
42. Almeida J.R., Price D.A., Papagno L., Arkoub Z.A., Sauce D., Bornstein E., et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med 204 (2007) 2473-2485
43. Precopio M.L., Betts M.R., Parrino J., Price D.A., Gostick E., Ambrozak D.R., et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 204 (2007) 1405-1416
44. Paoloni M., and Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 8 (2008) 147-156
45. Glass E.N., Kapatkin A., Vite C., and Steinberg S.A. A modified bilateral transfrontal sinus approach to the canine frontal lobe and olfactory bulb: surgical technique and five cases. J Am Anim Hosp Assoc 36 (2000) 43-50
46. Southgate T., Kroeger K.M., Liu C., Lowenstein P.R., and Castro M.G. Gene transfer into neural cells in vitro using adenoviral vectors. Curr Protoc Neurosci (2008) [Chapter 4, Unit 4.23]